Company:  BIOFRONTERA AG (BFRA)
Form Type:  6-K
Filing Date:  5/26/2020 
CIK:  0001712641 
Address:  HEMMELRATHER WEG 201 
City, State, Zip:  LEVERKUSEN,  D-51377 
Telephone:  011 49 214 876 00 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$8.04  
Change: 
0.16 (2.03%)  
Trade Time: 
03:00 PM EST  
Market Cap: 
$180.29M
Trade BFRA now with 

© 2020  
Description of Business
Our company was formed in 1997 by Professor Hermann Lübbert, Ph.D., who currently serves as chairman of our management board and our chief executive officer, as a limited liability company (Gesellschaft mit beschränkter Haftung or GmbH) under German law and under the name "BioFrontera Laboratories GmbH" to provide services to the pharmaceutical industry. 38 In September 1997, the company was renamed "BioFrontera Pharmaceuticals GmbH" and commenced its current operations, which include the development, marketing, sales, manufacturing and distribution of drugs and medical devices, cosmetics, and other dermatology-related products. On August 24, 2000, our company was converted into a German stock corporation (Aktiengesellschaft or AG), and on November 27, 2003, our company was renamed "Biofrontera AG".
Register and access this filing in:     
  FORM 6-K
    SIGNATURES
  EXHIBIT 99.1